scholarly journals Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

2017 ◽  
Vol 135 (3) ◽  
pp. 545-552 ◽  
Author(s):  
Jay-Jiguang Zhu ◽  
◽  
Petya Demireva ◽  
Andrew A. Kanner ◽  
Susan Pannullo ◽  
...  
Keyword(s):  
Phase Iii ◽  
Newly Diagnosed ◽  
Cognitive Screening ◽  
Health Related Quality ◽  
Phase Iii Trial ◽  
Tumor Treating Fields ◽  
Related Quality ◽  
Health Related ◽  
Newly Diagnosed Glioblastoma

scholarly journals QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

2017 ◽  
Vol 19 (suppl_6) ◽  
pp. vi206-vi206
Author(s):  
Martin J B Taphoorn ◽  
Linda Dirven ◽  
Sophie Taillibert ◽  
Jerôme Honnorat ◽  
Thomas Chen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Phase Iii ◽  
Newly Diagnosed ◽  
Health Related Quality ◽  
Phase Iii Trial ◽  
Tumor Treating Fields ◽  
Related Quality ◽  
Health Related ◽  
Newly Diagnosed Glioblastoma

scholarly journals Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma

JAMA Oncology ◽  
2018 ◽  
Vol 4 (4) ◽  
pp. 495 ◽  
Author(s):  
Martin J. B. Taphoorn ◽  
Linda Dirven ◽  
Andrew A. Kanner ◽  
Gitit Lavy-Shahaf ◽  
Uri Weinberg ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Newly Diagnosed ◽  
Health Related Quality ◽  
Tumor Treating Fields ◽  
Related Quality ◽  
Health Related ◽  
Newly Diagnosed Glioblastoma
Sign in / Sign up

Export Citation Format

Share Document